MedPath

Anesiva, Inc.

Anesiva, Inc. logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1999-01-01
Employees
100
Market Cap
-
Website
http://anesiva.com

Clinical Trials

9

Active:0
Completed:5

Trial Phases

3 Phases

Phase 1:2
Phase 2:3
Phase 3:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 2
3 (37.5%)
Phase 3
3 (37.5%)
Phase 1
2 (25.0%)

Satisfaction With Pediatric Intravenous Catheter Placement in the Emergency Department

Terminated
Conditions
Intravenous Placement Procedure
First Posted Date
2008-10-03
Last Posted Date
2010-05-25
Lead Sponsor
Anesiva, Inc.
Target Recruit Count
200
Registration Number
NCT00766181

Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement

Phase 2
Terminated
Conditions
Arthroplasty
Interventions
Drug: Placebo
Drug: 4975, highly purified capsaicin
First Posted Date
2008-05-23
Last Posted Date
2009-05-04
Lead Sponsor
Anesiva, Inc.
Target Recruit Count
118
Registration Number
NCT00683267
Locations
🇺🇸

Alabama Clinical Therapeutics, LLC, Birmingham, Alabama, United States

🇺🇸

Lotus Clinical Research, Inc., Arcadia, California, United States

🇺🇸

Glendale Adventist Medical Center, Glendale, California, United States

and more 6 locations

Safety and Efficacy Study of 4975 in Patients Undergoing Total Knee Replacement

Phase 3
Completed
Conditions
Total Knee Arthroplasty (Replacement)
Interventions
Drug: 4975 - 5 mg
Drug: Placebo Comparator
Drug: 4975, 15 and 5 mg
First Posted Date
2008-05-21
Last Posted Date
2009-05-04
Lead Sponsor
Anesiva, Inc.
Target Recruit Count
214
Registration Number
NCT00681356
Locations
🇺🇸

Alabama Clinical Therapeutics, LLC, Birmingham, Alabama, United States

🇺🇸

Springhill Medical Center, Mobile, Alabama, United States

🇺🇸

Hellen Keller Hospital, Sheffield, Alabama, United States

and more 21 locations

Safety and Tolerability of 4975 in Patients Undergoing Arthroscopic Surgery to Repair the Rotator Cuff of the Shoulder

Phase 2
Terminated
Conditions
Rotator Cuff Repair of the Shoulder
Interventions
Drug: 4975 - Highly purified capsaicin
Drug: Placebo
First Posted Date
2008-05-06
Last Posted Date
2009-05-04
Lead Sponsor
Anesiva, Inc.
Target Recruit Count
24
Registration Number
NCT00672568
Locations
🇰🇷

Kyungpook National university Hospital, Daegu, Jung-gu, Korea, Republic of

🇰🇷

Seoul National University Hospital, Seoul, Kyunggido, Korea, Republic of

🇰🇷

Gyeongsang National University Hospital, Jinju, Kyungsangnamdo, Korea, Republic of

and more 1 locations

Efficacy and Safety Study of 4975 to Manage Pain of Bunionectomy

Phase 3
Completed
Conditions
Pain
Interventions
Drug: 4975
Drug: Placebo
First Posted Date
2008-04-11
Last Posted Date
2009-05-04
Lead Sponsor
Anesiva, Inc.
Target Recruit Count
300
Registration Number
NCT00656578
Locations
🇺🇸

Foot and Ankle Institute, Bakersfield, California, United States

🇺🇸

Crossroads Research, Inc., Owings Mills, Maryland, United States

🇺🇸

Scirex Research Center, Salt Lake City, Utah, United States

and more 2 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath